返回 Agenda
Session 1: Landscape Analysis of Real World Evidence and Current Regulatory Frameworks
Session Chair(s)
Mark Stewart, PhD
Vice President, Science Policy
Friends of Cancer Research, United States
Learning Objective : At the conclusion of this session, participants should be able to:- Assess the scope of the conference
- Describe the sources of real world evidence
- Explain how RWE can contribute to drug development
Speaker(s)
FDA Update
Jacqueline A. Corrigan-Curay, JD, MD
FDA, United States
Principal Deputy Center Director, Center for Drug Evaluation and Research (CDER)
Updates on Conceptual Frameworks for Regulatory Use
Morgan Romine, MPA
Duke University, United States
Chief of Staff